Cargando…

Preclinical activity of melflufen (J1) in ovarian cancer

Ovarian cancer carries a significant mortality. Since symptoms tend to be minimal, the disease is often diagnosed when peritoneal metastases are already present. The standard of care in advanced ovarian cancer consists of platinum-based chemotherapy combined with cytoreductive surgery. Unfortunately...

Descripción completa

Detalles Bibliográficos
Autores principales:	Carlier, Charlotte, Strese, Sara, Viktorsson, Kristina, Velander, Ebba, Nygren, Peter, Uustalu, Maria, Juntti, Therese, Lewensohn, Rolf, Larsson, Rolf, Spira, Jack, De Vlieghere, Elly, Ceelen, Wim P., Gullbo, Joachim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312315/ https://www.ncbi.nlm.nih.gov/pubmed/27528037 http://dx.doi.org/10.18632/oncotarget.11163

Ejemplares similares

In vitro and in vivo anti-leukemic activity of the peptidase-potentiated alkylator melflufen in acute myeloid leukemia
por: Strese, Sara, et al.
Publicado: (2016)

In vitro and in vivo activity of melflufen (J1)in lymphoma
por: Delforoush, Maryam, et al.
Publicado: (2016)

Melflufen - a peptidase-potentiated alkylating agent in clinical trials
por: Wickström, Malin, et al.
Publicado: (2017)

Effects of hypoxia on human cancer cell line chemosensitivity
por: Strese, Sara, et al.
Publicado: (2013)

Data on in vivo selection of SK-OV-3 Luc ovarian cancer cells and intraperitoneal tumor formation with low inoculation numbers
por: De Vlieghere, Elly, et al.
Publicado: (2016)

Melflufen: A Peptide–Drug Conjugate for the Treatment of Multiple Myeloma
por: Mateos, María-Victoria, et al.
Publicado: (2020)

Mechanistic characterization of a copper containing thiosemicarbazone with potent antitumor activity
por: Karlsson, Henning, et al.
Publicado: (2017)

Ephrin B3 interacts with multiple EphA receptors and drives migration and invasion in non-small cell lung cancer
por: Efazat, Ghazal, et al.
Publicado: (2016)

Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest
por: Lundholm, L, et al.
Publicado: (2013)

Harnessing the lysosome-dependent antitumor activity of phenothiazines in human small cell lung cancer
por: Zong, D, et al.
Publicado: (2014)

Improved xenograft efficiency of esophageal adenocarcinoma cell lines through in vivo selection
por: Melsens, Elodie, et al.
Publicado: (2017)

The prognostic implications of Notch1, Hes1, Ascl1, and DLL3 protein expression in SCLC patients receiving platinum-based chemotherapy
por: Tendler, Salomon, et al.
Publicado: (2020)

Comparison and optimization of nanoscale extracellular vesicle imaging by scanning electron microscopy for accurate size-based profiling and morphological analysis
por: Cavallaro, Sara, et al.
Publicado: (2021)

The Role of Belantamab Mafodotin, Selinexor, and Melflufen in Multiple Myeloma
por: McCurdy, Arleigh, et al.
Publicado: (2022)

EPHA2 Interacts with DNA-PK(cs) in Cell Nucleus and Controls Ionizing Radiation Responses in Non-Small Cell Lung Cancer Cells
por: Kaminskyy, Vitaliy O., et al.
Publicado: (2021)

Nanoparticulate Quillaja saponin induces apoptosis in human leukemia cell lines with a high therapeutic index
por: Hu, Kefei, et al.
Publicado: (2010)

DKK1 is a potential novel mediator of cisplatin-refractoriness in non-small cell lung cancer cell lines
por: Salim, Hogir, et al.
Publicado: (2015)

Cytotoxic Alkylynols of the Sponge Cribrochalina vasculum: Structure, Synthetic Analogs and SAR Studies
por: Kovalerchik, Dimitry, et al.
Publicado: (2022)

The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA.
por: Olivier, Timothée, et al.
Publicado: (2022)

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
por: Richardson, Paul G., et al.
Publicado: (2021)

A novel tumor spheroid model identifies selective enhancement of radiation by an inhibitor of oxidative phosphorylation
por: Karlsson, Henning, et al.
Publicado: (2019)

Aminopeptidase Expression in Multiple Myeloma Associates with Disease Progression and Sensitivity to Melflufen
por: Miettinen, Juho J., et al.
Publicado: (2021)

APS8, a Polymeric Alkylpyridinium Salt Blocks α7 nAChR and Induces Apoptosis in Non-Small Cell Lung Carcinoma
por: Zovko, Ana, et al.
Publicado: (2013)

Profiling of extracellular vesicles of metastatic urothelial cancer patients to discover protein signatures related to treatment outcome
por: Viktorsson, Kristina, et al.
Publicado: (2022)

Compounds from the marine sponge Cribrochalina vasculum offer a way to target IGF-1R mediated signaling in tumor cells
por: Zovko, Ana, et al.
Publicado: (2016)

Exploiting Electrostatic Interaction for Highly Sensitive Detection of Tumor-Derived Extracellular Vesicles by an Electrokinetic Sensor
por: Sahu, Siddharth Sourabh, et al.
Publicado: (2021)

Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
por: Alkasalias, Twana, et al.
Publicado: (2022)

Correction: Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells
por: Alkasalias, Twana, et al.
Publicado: (2022)

Systems biology approaches to develop innovative strategies for lung cancer therapy
por: Viktorsson, K, et al.
Publicado: (2014)

Age and cellular context influence rectal prolapse formation in mice with caecal wall colorectal cancer xenografts
por: Tommelein, Joke, et al.
Publicado: (2016)

Authors’ reply: Perspective: The approval and withdrawal of melphalan flufenamide (melflufen): Implications for the state of the FDA
por: Schjesvold, Fredrik H, et al.
Publicado: (2022)

Hypoxia imaging with (18)F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts
por: Melsens, Elodie, et al.
Publicado: (2018)

Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia
por: Hååg, Petra, et al.
Publicado: (2022)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
por: Sgherza, Nicola, et al.
Publicado: (2021)

Comparison of the cytotoxic activity of melphalan with L-prolyl-m-L-sarcolysyl-L-p-fluorophenylalanine in human tumour cell lines and primary cultures of tumour cells from patients.
por: Larsson, R., et al.
Publicado: (1998)

Detection of Tumor-Associated Membrane Receptors on Extracellular Vesicles from Non-Small Cell Lung Cancer Patients via Immuno-PCR
por: Stiller, Christiane, et al.
Publicado: (2021)

Melflufen, a peptide‐conjugated alkylator, is an efficient anti‐neo‐plastic drug in breast cancer cell lines
por: Schepsky, Alexander, et al.
Publicado: (2020)

Characterizing single extracellular vesicles by droplet barcode sequencing for protein analysis
por: Banijamali, Mahsan, et al.
Publicado: (2022)

Chemosensitization by phenothiazines in human lung cancer cells: impaired resolution of γH2AX and increased oxidative stress elicit apoptosis associated with lysosomal expansion and intense vacuolation
por: Zong, D, et al.
Publicado: (2011)

Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia
por: Hallböök, Helene, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vui7panjr77q58vm85uch9p0kg